Trial Profile
Factor influencing tacrolimus blood concentration switching after continuous intravenous infusion to oral administration in allogeneic hematopoietic stem cell transplan recipients with hematological maliganancies
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 May 2017
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Fluconazole; Itraconazole; Omeprazole; Voriconazole
- Indications Haematological malignancies
- Focus Pharmacokinetics
- 16 May 2017 New trial record